8-K/A: Vireo Growth Inc. Amends 8-K to Include Eaze Merger Financials

Vireo Growth Inc. filed an amendment to its Form 8-K to provide audited financial statements for Eaze Inc. and pro forma combined financial information following their merger.

Summary

• Vireo Growth Inc. (the Company) has filed an amendment (Amendment No. 1) to its Current Report on Form 8-K, originally filed on April 6, 2026.
• This amendment is specifically to supplement Item 9.01 of the Prior Form 8-K by providing the required financial statements for Eaze Inc. (Eaze) and pro forma financial information related to the merger.
• The audited consolidated financial statements of Eaze and its subsidiaries as of December 31, 2025, and for the year then ended, are included as Exhibit 99.1.
• Unaudited pro forma condensed combined financial statements of Vireo Growth Inc. and Eaze Inc. as of December 31, 2025, are included as Exhibit 99.2.
• The merger, completed on April 1, 2026, involved Vireo's wholly owned subsidiary merging with Eaze, with Eaze surviving as a wholly owned subsidiary.
• The amendment does not modify or update any other disclosures from the original Form 8-K.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the significant pro forma net loss reported for the combined entity and the fact that it's an amendment to correct an incomplete initial filing.

Positives

• The filing provides necessary financial disclosures for the recently completed merger, enhancing transparency for investors.
• Inclusion of Eaze's audited financial statements and pro forma combined financials allows for a clearer understanding of the combined entity's financial position and performance.
• The pro forma statements offer insight into the potential financial impact of the merger, even though they are based on estimates.

Negatives

• The filing is an amendment, indicating that the initial report was incomplete regarding essential financial information for the merger.
• The pro forma financial information is unaudited and based on preliminary estimates, which are subject to change and may differ materially from actual results.
• The pro forma statements do not include adjustments for potential synergies, dis-synergies, future operating efficiencies, cost savings, or integration costs, limiting their predictive value.

Risks

• The cannabis industry operates in a complex regulatory environment where state laws conflict with U.S. federal law, creating inherent legal and operational risks.
• Banking relationships in the cannabis industry are subject to heightened scrutiny and potential disruption due to federal illegality, posing a risk to operations.
• Eaze's operations are subject to evolving state and local regulations, with potential for fines, restrictions, or loss of permits.
• The company is subject to the limitations of IRC Section 280E, which restricts business expense deductions for cannabis companies, impacting tax liabilities.
• The reclassification of certain marijuana products to Schedule III under the Controlled Substances Act, while potentially beneficial, introduces uncertainty as the company evaluates its impact.
• The merger itself carries integration risks and the potential for actual results to differ materially from pro forma projections.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. It primarily provides historical financial information and pro forma combined statements related to a completed merger. The pro forma statements indicate a significant net loss for the combined entity in 2025, but do not offer future projections.

Management Comments

• Management of Eaze is responsible for the preparation and fair presentation of its consolidated financial statements and internal controls.
• Management of Eaze evaluated conditions and events that raise substantial doubt about the Company's ability to continue as a going concern and concluded no such doubt exists for at least one year after the financial statements' issuance date.
• Management of Vireo Growth Inc. concluded that the Company is the accounting acquirer in the Eaze merger.
• Management of Vireo Growth Inc. is still in the process of finalizing the purchase price allocation and valuation of equity instruments and contingent consideration related to the Eaze merger.

Industry Context

StockSavvy.ai notes that this filing highlights the ongoing consolidation within the cannabis industry, with larger entities like Vireo Growth Inc. acquiring and integrating smaller players like Eaze Inc. The inclusion of Eaze's financials, particularly its significant net loss and the complexities of operating under federal prohibition (IRC 280E), underscores the financial challenges and regulatory hurdles prevalent in the sector.

Comparison to Industry Standards

• Eaze's net loss of $24.1 million on $141.1 million in sales for 2025 indicates a negative net profit margin of approximately -17.1%. This is a common challenge in the cannabis industry due to high operating costs and regulatory burdens, particularly Section 280E of the IRS code, which limits deductions.
• The pro forma combined net loss of $94.9 million on $409.9 million in revenue for 2025 suggests a combined net profit margin of approximately -23.2%. This indicates that the combined entity is still operating at a significant loss, which is not uncommon for companies in the growth and consolidation phase of the cannabis market.
• The significant amount of intangible assets and goodwill ($117.5 million and $94.0 million respectively in pro forma combined balance sheet) reflects the common practice of valuing cannabis licenses and brand recognition highly, often leading to substantial amortization and impairment risks if market conditions or regulations change.

Legal Proceedings

• As of December 31, 2025, Eaze Inc. had no pending or threatened lawsuits that could reasonably be expected to have a material effect on its operations.
• No directors, officers, or affiliates of Eaze Inc. were involved in litigation adverse to the company's interests.

Stakeholder Impact

• Shareholders of Vireo Growth Inc. are impacted by the dilution from the issuance of 90,379,591 subordinate voting shares as merger consideration and potential future earnout shares.
• Former Eaze stockholders are now shareholders of Vireo Growth Inc. and may receive additional shares based on earnout targets.
• Employees of Eaze may receive restricted stock units (RSUs) as part of the merger consideration and retention incentives.
• Creditors and suppliers of both Vireo and Eaze will be subject to the combined entity's financial health and payment policies.

Next Steps

• Vireo Growth Inc. will continue to finalize the purchase price allocation for the Eaze merger, which is expected to be completed within twelve months of the closing date.
• Management is evaluating the impact of the U.S. Department of Justice's reclassification of certain marijuana products to Schedule III on the company's operations, regulatory compliance, and tax position.

Key Dates

Recommendation

The filing reveals a significant pro forma net loss for the combined entity, indicating ongoing financial challenges in the cannabis sector, exacerbated by regulatory complexities like Section 280E. While the merger represents a strategic move for consolidation, the immediate financial performance is concerning. Therefore, a 'hold' recommendation is appropriate pending further clarity on integration success, path to profitability, and the impact of evolving cannabis regulations.

Keywords

Vireo Growth Inc., Eaze Inc., Merger, Form 8-K/A, Amendment, Financial Statements, Pro Forma, Cannabis Industry